The Master is part of the Myllenium Award competition to win a scholarship
8 April 2021 - The new II level university Master's degree in "Clinical research, open innovation and market access in the digital era", conceived byUniversità Campus Bio-Medico di Roma in collaboration with Anac. The main objective of the Master is to provide the fundamental knowledge to govern the entire process of creating and placing a new drug for human health on the market.
Why participate today in a Master's in clinical research, open innovation and market access?
The market has a growing demand for professionals who know how to understand and govern the complexities of the drug world, of the constantly evolving device and open to collaboration between different professional figures. Between 2014 and 2019, the pharmaceutical industry increased employment more than all sectors: +10% compared to +5% on average. This growth was also accompanied by an increase in investments, made possible by the business decision to invest in the country by leveraging our strengths, starting with the quality of Human Resources. All while the digital revolution is opening up previously unthinkable opportunities: increased productivity, expansion of the product portfolio and improvement of the customer experience.
Participants will acquire skills related to the scope of the project management, of negotiation and risk and innovation management. In fact, clinical trials are to all intents and purposes the management of a complex project in which various stakeholders participate, all bearers of fundamental interests for the success of the health project, but with whom careful negotiation is essential to achieve the objective and protect the interests of the parties.
Ideal for those who are already professionals in the sector, for those who want to perfect their CV and for recent graduates who want to further specialize. Once the course is finished, you will be able to enter different areas of the world of drugs and medical devices:
- Contract Research Organizations;
- University health and hospital units;
- Research institutions;
- hospitalization institutions;
- Pharmaceutical companies
The Master falls within the call Myllenium Award 2021 for the 'assignment of a full coverage scholarship in favor of a deserving participant. To participate in the call, the scholarship application must be submitted by 10 May 2021 following the instructions given in the regulation available at the following link: https://myllenniumaward.org/myjob/.
It is specified that the participants in the Myllenium Award 2021 call must, by the same deadline, submit the application for admission to the Master.
The deadline for entries is set forJune 11, 2021.
